Hormone therapy and cancer
Halse, S.Aasted.
Ugeskrift for Laeger 166(8): 719; Author Reply 719-21
2004
ISSN/ISBN: 0041-5782 PMID: 15042826 Document Number: 582452
Document emailed within 1 workday
Related Documents
Tsukamoto, T.; Fukui, I.; Kihara, K.; Goto, S.; Kitahara, S.; Kobayashi, T.; Kojima, S.; Oshima, H. 1996: Combined hormone-chemotherapy for stage D2 prostatic cancer: starting time of chemotherapy in relation to hormone therapy Hinyokika Kiyo. Acta Urologica Japonica 42(5): 351-356Nozaki, H.; Funahashi, H.; Sato, Y.; Imai, T.; Oike, E.; Kato, M.; Takagi, H. 1991: Study of hormone replacement therapy following total thyroidectomy in thyroid cancer--with special reference to the analysis of thyroid hormone peripheral effects, using indirect calorimetry Nihon Geka Gakkai Zasshi 92(12): 1700-1707
Machida, T.; Ikemoto, I. 1987: Hormone therapy of male genital cancer (prostatic cancer) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(10): 2845-2852
Li, L.; Ji, J.; Wang, J.-B.; Niyazi, M.; Qiao, Y.-L.; Boffetta, P. 2012: Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy Chinese Journal of Cancer Research 24(1): 9-17
Kennedy, B.J. 1970: Hormone therapy in cancer Geriatrics 25(10): 106-112
Smith, P.H.; Akdas, A.; Mason, M.K.; Richards, B.; Robinson, M.R.; de Pauw, M.; Sylvester, R. 1980: Hormone therapy in prostatic cancer Acta Urologica Belgica 48(1): 98-105
Baber, R.J.; Studd, J.W. 1989: Hormone replacement therapy and cancer British Journal of Hospital Medicine 41(2): 142; 144-146; 148-149
Joseph, K.S. 1995: Breast cancer and hormone-replacement therapy New England Journal of Medicine 333(20): 1356; Author Reply 1357-1358
Wehrlin, N. 1983: Therapeutics: hormone therapy for breast cancer Revue de l'Infirmiere 33(11): 35-38
Matsushita, H.; Wakatsuki, A. 2012: Hormone replacement therapy and cancer risk Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 4): 805-809
St-Arnaud, R.; Lachance, R.; Dupont, A.; Labrie, F. 1986: Stimulation of the circulating levels of glycoprotein hormone alpha-subunit after combined administration of a luteinizing hormone-releasing hormone (LHRH) agonist and flutamide in patients with cancer of the prostate Clinical and Investigative Medicine. Medecine Clinique et Experimentale 9(4): 215-221
Rageth, J.C.; Birkhäuser, M.; Castiglione, M. 1998: Hormone substitution therapy after breast cancer--a reevaluation Schweizerische Medizinische Wochenschrift 128(26): 1037-1042
Köhler, A.; Noss, W.; Dobberstein, N.; Stoltmann, R.; Pohl, J. 1986: Hormone therapy of metastasizing breast cancer with tamoxifen Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 41(1): 6-9
Levgur, M. 2004: Hormone therapy for women after breast cancer: a review Journal of Reproductive Medicine 49(7): 510-526
Tavani, A.; La Vecchia, C.; Brinton, L.A.; McTiernan, A. 2001: Hormone replacement therapy and risk of endometrial cancer Tumori 87(5): S20-S21
Arai, Y.; Ogawa, O. 2019: Hormone Therapy and Castration Resistance of Prostate Cancer Canadian Journal of Urology 26(2): 9686
Ersbøll, J. 2004: Breast cancer, mammography screening and hormone therapy Ugeskrift for Laeger 166(36): 3113-3114
Chen, F.-P. 2009: Postmenopausal hormone therapy and risk of breast cancer Chang Gung Medical Journal 32(2): 140-147
Vorob'ev, N.A.; Nosov, A.K.; Vorob'ev, A.V.; Moiseenko, V.M. 2010: New perspectives in the drug therapy of hormone-resistant prostate cancer Voprosy Onkologii 56(6): 645-653
Dryzhak, V.I. 1989: Estrogen antagonists and inhibitors in hormone therapy of breast cancer Voprosy Onkologii 35(7): 771-778